Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular Subtypes

<div>Immune-based properties of the 2 molecular subtypes in the RNAseq data set. (a) ssGSEA compared the 28 immune cell scores in the 2 subtypes. (b) MCP-Counter compared the 10 immune cell scores in the 2 subtypes. (c) ESTIMATE compared the StromalScore values in the 2 subtypes. (d) ESTIMATE compared the ImmuneScore values in the 2 subtypes. (e) ESTIMATE compared the ESTIMATEScore values in the 2 subtypes.</div>

Stem Cells International

fig2

Figure 2

Figure 2: Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular Subtypes 

Figure 2 | Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular Subtypes 